CovidDataNet.NRW Project
Severe COVID-19 treatment
ResearchActive
Key Facts
About Chimera Biotec
Chimera Biotec is a specialty CRO and immunoassay platform provider focused on ultra-sensitive and technically demanding bioanalysis for large-molecule therapeutics. Founded in 2000, the company has established itself as the world's leading Immuno-PCR technology vendor, offering services on its proprietary Imperacer® platform as well as other technologies like Simoa® and MSD. Its mission is to provide highly sensitive, accurate, and reliable bioanalytical data to support all phases of modern drug development, particularly for biologics, biosimilars, and biobetters, under strict GLP/GCP quality regimes.
View full company profile